United States: Intellectual Property

The landscape of tariff enforcement is intensifying, creating significant compliance, financial, and operational challenges for importers.

RSL Media has introduced the Human Consent Standard, a machine-readable protocol allowing individuals to declare whether AI systems may use their creative works, identity, likeness, voice, characters, or marks. While endorsed by major entertainment industry figures and organizations, the voluntary standard's effectiveness depends on pending federal legislation like the NO FAKES Act, voluntary adoption by AI developers, and its ability to withstand contractual pressures that could undermine its protective fu

A professional photographer sued Iron Builders for copyright infringement after discovering his photograph on their business website. When Iron Builders failed to timely respond to a summary judgment motion, the court examined whether technical issues with electronic filing notices and alleged surprise constituted good cause for the delay.

Teva Pharmaceuticals and Polpharma Biologics have entered into a global licensing agreement for the commercialization of a biosimilar candidate to Genentech's OCREVUS (ocrelizumab), a treatment for multiple sclerosis. The agreement combines Polpharma Biologics' development expertise with Teva's commercial capabilities across major markets including the United States, Europe, and several other territories. Under the terms, Polpharma Biologics will handle development and manufacturing while Teva manages regul

When a non-U.S. company obtains a U.S. trademark registration based on a foreign registration without U.S. use, failing to file the required Declaration of Use within six years can result in cancellation with serious consequences. A recent TTAB decision demonstrates how a lapsed registration loses all protective value, even against later-filed confusingly similar marks that were registered while the original registration was still active.

RSL Media has introduced the Human Consent Standard, a machine-readable protocol allowing individuals to declare whether AI systems may use their creative works, identity, likeness, voice, characters, or marks. While endorsed by major entertainment industry figures and organizations, the voluntary standard's effectiveness depends on pending federal legislation like the NO FAKES Act, voluntary adoption by AI developers, and its ability to withstand contractual pressures that could undermine its protective fu

The Federal Circuit reversed inter partes review (IPR) estoppel on both invalidity grounds Valve sought to assert at trial, finding the evidence of prior art discoverability was either underdeveloped or tainted...

Two recent Federal Circuit decisions offer complementary guidance on a recurring question in patent law: what must a patent specification disclose to satisfy written description...

The landscape of tariff enforcement is intensifying, creating significant compliance, financial, and operational challenges for importers.

Although a refined description may not be in hand when the complaint is filed, it should be prepared without delay so as to be available when the need to specify the substance of the trade secrets arises.

Defense contractors using artificial intelligence in government contract performance face a critical question about intellectual property rights. While AI-assisted work doesn't automatically transfer proprietary systems to the government, vague transparency and explainability clauses in contracts can quietly expand disclosure obligations and erode decades-old trade secret protections.

Molecules have long been the primary asset in life sciences. Companies develop therapeutics, protect them with patents, and license or sell them. With the rise of artificial intelligence (AI), the data generated...